Publicado em 21 de set de 2015
Martin Shkrelli, CEO of Turing Pharmaceuticals, defended the decision to raise the price of Daraprim--a toxoplasmosis drug that is frequently prescribed to HIV and AIDS patients--from $13.50 a tablet to $750 a tablet overnight. In an interview Monday with Bloomberg TV's Betty Liu, explaining that they "need to turn a profit on the drug," Shkrelli defended his position in the face of widespread criticism that even came from Hillary Clinton. Is this the free market at work, or a hedge fund manager putting profit ahead of human life? We look at the drastic price increase and fallout on the Lip News with Margaret Howell and Elliot Hill.
http://www.nytimes.com/2015/09/21/bus...
Newest Lip News playlist:
https://www.youtube.com/watch?v=hwnlc...
BUZZSAW interview clips -
https://www.youtube.com/watch?v=F5rkn...
CRIME TIME clips playlist -
https://www.youtube.com/watch?v=5ZBeK...
BYOD (Bring Your Own Doc) Highlight Videos-
https://www.youtube.com/watch?v=5fKc1...
MEDIA MAYHEM short videos playlist -
https://www.youtube.com/watch?v=-7HUk...
http://www.thelip.tv
https://www.facebook.com/thelip.tv
http://www.youtube.com/theliptv
http://www.nytimes.com/2015/09/21/bus...
Newest Lip News playlist:
https://www.youtube.com/watch?v=hwnlc...
BUZZSAW interview clips -
https://www.youtube.com/watch?v=F5rkn...
CRIME TIME clips playlist -
https://www.youtube.com/watch?v=5ZBeK...
BYOD (Bring Your Own Doc) Highlight Videos-
https://www.youtube.com/watch?v=5fKc1...
MEDIA MAYHEM short videos playlist -
https://www.youtube.com/watch?v=-7HUk...
http://www.thelip.tv
https://www.facebook.com/thelip.tv
http://www.youtube.com/theliptv
Nenhum comentário:
Postar um comentário